A Study of SGN-B6A in Chinese Participants With Advanced Solid Tumors

NCT06549816 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

6

Enrollment

INDUSTRY

Sponsor class

Conditions

Carcinoma, Non-Small Cell Lung
Squamous Cell Carcinoma of Head and Neck
Esophageal Squamous Cell Carcinoma
Gastric Adenocarcinoma
Esophageal Adenocarcinoma
Gastroesophageal Junction Adenocarcinoma

Interventions

DRUG: sigvotatug vedotin

Sponsor

Seagen, a wholly owned subsidiary of Pfizer